Show Health and Fitness Publications

Tue, May 1, 2012

[ Tue, May 01st 2012 ] - Market Wire

Prana Comments on Archives of Neurology Publicati .. Role of Brain Metals in Huntington Disease Progre

[ Tue, May 01st 2012 ] - Market Wire

Dr. David L. Blecker MD, MPH, F.A.C.P. Joins Iner .. Develop and Market Products to Penetrate Nephrolo

[ Tue, May 01st 2012 ] - Market Wire

BIOLASE Named as Finalist in the Medical Devices .. egory for TechAmerica High-Tech Innovation Awards

[ Tue, May 01st 2012 ] - Market Wire

Titan Medical Inc. Announces Research Agreement with ARMA Lab at Vanderbilt University

[ Tue, May 01st 2012 ] - Market Wire

Ohr Pharmaceutical Announces Ophthalmic Scientific Advisory Board

[ Tue, May 01st 2012 ] - Market Wire

Celsion Corporation and Focused Ultrasound Founda .. oring ThermoDox(R) Combined With Focused Ultrasou

[ Tue, May 01st 2012 ] - Market Wire

Amarantus BioSciences to Present at the New York .. ation (NYBA) 21st Annual Meeting on May 2nd, 2012

[ Tue, May 01st 2012 ] - Market Wire

ISTA Pharmaceuticals Reports Positive, Topline Re .. al Trial of BEPOSONE(TM) Nasal Spray for the Trea

[ Tue, May 01st 2012 ] - Market Wire

Horizon Pharma to Host Conference Call and Webcas .. st Quarter 2012 Financial Results on May 10, 2012

[ Tue, May 01st 2012 ] - Market Wire

Aeterna Zentaris to Announce First Quarter 2012 F .. ts and Hold Annual Shareholders Meeting on May 9,

[ Tue, May 01st 2012 ] - Market Wire

Orexigen Therapeutics Schedules May 9, 2012 Webca .. esults for the First Quarter Ended March 31, 2012

[ Tue, May 01st 2012 ] - Market Wire

Rigel Announces First Quarter 2012 Financial Results

[ Tue, May 01st 2012 ] - Market Wire

Techne Corporation Declares Dividend

[ Tue, May 01st 2012 ] - Market Wire

STAAR Surgical to Present at the Deutsche Bank 37th Annual Health Care Conference

[ Tue, May 01st 2012 ] - Market Wire

Delcath To Report Fiscal 2012 First Quarter Results And Conduct Conference Call

[ Tue, May 01st 2012 ] - Market Wire

MillerCoors Reissuing Purchase Order

[ Tue, May 01st 2012 ] - Market Wire

ShangPharma Corporation Files 2011 Annual Report on Form 20-F

[ Tue, May 01st 2012 ] - Market Wire

Inovio Pharmaceuticals Granted U.S. Patent Protec .. nthetic Vaccine for Cervical Dysplasia and Cancer

Mon, April 30, 2012

[ Mon, Apr 30th 2012 ] - Market Wire

Pivotal Therapeutics Announces 2011 Financial Results

[ Mon, Apr 30th 2012 ] - Market Wire

Metropolitan Health Networks to Announce First Quarter 2012 Results

[ Mon, Apr 30th 2012 ] - Market Wire

Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission

[ Mon, Apr 30th 2012 ] - Market Wire

Halozyme to Host First Quarter 2012 Financial Results Conference Call

[ Mon, Apr 30th 2012 ] - Market Wire

The Medicines Company to Participate in the Deutsche Bank 37th Annual Healthcare Conference

[ Mon, Apr 30th 2012 ] - Market Wire

Affymax Announces First Quarter 2012 Financial Results Teleconference and Webcast

[ Mon, Apr 30th 2012 ] - Market Wire

Salix Pharmaceuticals Announces Extension of Crofelemer NDA Priority Review

[ Mon, Apr 30th 2012 ] - Market Wire

Ergoresearch Announces Creation of Ergorecherche France

[ Mon, Apr 30th 2012 ] - Market Wire

Mylan Announces Settlement Agreement for its First-to-File Generic Version of Nuvigil

[ Mon, Apr 30th 2012 ] - Market Wire

Five Star Quality Care, Inc. to Present at the Deutsche Bank Healthcare Conference on May 7, 2012

[ Mon, Apr 30th 2012 ] - Market Wire

Celsion to Present at the 37th Annual Deutsche Bank Health Care Conference

[ Mon, Apr 30th 2012 ] - Market Wire

St. Jude Medical to Present at the 37th Annual Deutsche Bank Health Care Conference

[ Mon, Apr 30th 2012 ] - Market Wire

ARIAD To Present at the Deutsche Bank 37th Annual Health Care Conference

[ Mon, Apr 30th 2012 ] - Market Wire

Rockwell Medical Completes Patient Enrollment in PRIME Clinical Study

[ Mon, Apr 30th 2012 ] - Market Wire

PolyTouch Medical Acquired by Covidien

[ Mon, Apr 30th 2012 ] - Market Wire

Sangamo BioSciences Nominates Saira Ramasastry To The Company's Board Of Directors

[ Mon, Apr 30th 2012 ] - Market Wire

Novadaq to Present at Deutsche Bank 37th Annual Health Care Conference

[ Mon, Apr 30th 2012 ] - Market Wire

Hologic to Acquire Gen-Probe

[ Mon, Apr 30th 2012 ] - Market Wire

Capital Senior Living Corporation to Present at D .. 37th Annual Health Care Conference on Monday, Ma

[ Mon, Apr 30th 2012 ] - Market Wire

MiMedx Selects Allen amp;; Caron for Inves .. ons, Media Relations and Corporate Communications

Sun, April 29, 2012

[ Sun, Apr 29th 2012 ] - Market Wire

RepliCel Clarifying News Release

[ Sun, Apr 29th 2012 ] - Market Wire

April 30, 2012 at 8:00 am Eastern Time

[ Sun, Apr 29th 2012 ] - Market Wire

Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC

[ Sun, Apr 29th 2012 ] - Market Wire

Haemonetics Signs Definitive Agreement to Acquire .. llection, Filtration and Processing Product Lines

Sat, April 28, 2012

[ Sat, Apr 28th 2012 ] - Market Wire

Mylan to Partner with United Nations and Clinton .. to Fight Diarrhea Fatalities in Children in India

Fri, April 27, 2012

[ Fri, Apr 27th 2012 ] - Market Wire

PDL BioPharma to Announce First Quarter 2012 Financial Results on May 3, 2012

[ Fri, Apr 27th 2012 ] - Market Wire

Quest Diagnostics Establishes Unique Healthcare I .. o Vital Patient Health Information;; 80 Mi

[ Fri, Apr 27th 2012 ] - Market Wire

Anthera Announces First Quarter 2012 Financial Report and Conference Call

[ Fri, Apr 27th 2012 ] - Market Wire

PFCD Capitol Hill Roundtable Explores IBM Watson .. logyas Value in Advancing Health Care Innovations

[ Fri, Apr 27th 2012 ] - Market Wire

Los nuevos datos sobre TYSABRI presentados en la .. ia Americana de Neurologa (AAN, por sus siglas en

[ Fri, Apr 27th 2012 ] - Market Wire

Cambrex To Announce First Quarter 2012 Financial Results On May 3, 2012

[ Fri, Apr 27th 2012 ] - Market Wire

Watson adquirir a Actavis Group por 4,25 mil millones de euros

[ Fri, Apr 27th 2012 ] - Market Wire

Valeant Pharmaceuticals to Present at Deutsche Ba .. curities, Inc. 37th Annual Health Care Conference

[ Fri, Apr 27th 2012 ] - Market Wire

MELA Sciences Named 2012 Bronze Edison Award Winner

[ Fri, Apr 27th 2012 ] - Market Wire

Bristol-Myers Squibb Invites Public to Listen to Webcast of 2012 Annual Meeting

[ Fri, Apr 27th 2012 ] - Market Wire

Vermillion Board of Directors Unanimously Nominates Paul R. Sohmer, M.D. for Company Director

[ Fri, Apr 27th 2012 ] - Market Wire

XTend Medical Corporation (XMDC) Begins Process to Change Name to MultiCorp International, Inc.

[ Fri, Apr 27th 2012 ] - Market Wire

Trimel Pharmaceuticals Corporation Completes Trea .. RT(TM) Allergic Rhinitis Special Population Study

[ Fri, Apr 27th 2012 ] - Market Wire

Lota S. Zoth Joins Orexigen Therapeutics Board of Directors

[ Fri, Apr 27th 2012 ] - Market Wire

Auf der 64. AAN-Jahrestagung vorgelegte neue Date .. as Engagement von Biogen Idec und Elan fr bessere

[ Fri, Apr 27th 2012 ] - Market Wire

Watson adquiere Actavis Group por 4.250 millones de euros

[ Fri, Apr 27th 2012 ] - Market Wire

Kindred Healthcare Announces Ventas Lease Renewals

[ Fri, Apr 27th 2012 ] - Market Wire

Covidien comunica i risultati del secondo trimestre

[ Fri, Apr 27th 2012 ] - Market Wire

Novo Nordisk plans 15 percent expansion of U.S. work force in 2012

[ Fri, Apr 27th 2012 ] - Market Wire

Crown Dynamics' AIR(R) Product Line Pass Testing

Thu, April 26, 2012

[ Thu, Apr 26th 2012 ] - Market Wire

Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference

[ Thu, Apr 26th 2012 ] - Market Wire

Johnson amp;; Johnson Holds 2012 Annual Meeting of Shareholders

[ Thu, Apr 26th 2012 ] - Market Wire

NPS Pharmaceuticals Among 100 Best Places to Work in New Jersey

[ Thu, Apr 26th 2012 ] - Market Wire

Notice of Paladin Labs' First Quarter 2012 Results Conference Call

[ Thu, Apr 26th 2012 ] - Market Wire

Tenet Announces Repurchase of $299 Million of Mandatory Convertible Preferred Stock

[ Thu, Apr 26th 2012 ] - Market Wire

QRxPharma's US Commercialisation Partner, Actavis .. armaceuticals, Inc.: MoxDuo IR on track for launc

[ Thu, Apr 26th 2012 ] - Market Wire

Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement with Teva

[ Thu, Apr 26th 2012 ] - Market Wire

Meridian Bioscience Reports Record Second Quarter .. ng Results Declares Regular Cash Dividend and Rea

[ Thu, Apr 26th 2012 ] - Market Wire

Low Side Effects Seen in Treatment With Delcath's Second Generation Hemofiltration Cartridge

[ Thu, Apr 26th 2012 ] - Market Wire

Cytokinetics Announces Presentation of Preclinica .. t the 2012 Experimental Biology Annual Conference

[ Thu, Apr 26th 2012 ] - Market Wire

Stem Cell Therapeutics Reports 2011 Year End Results

[ Thu, Apr 26th 2012 ] - Market Wire

Incyte Reports 2012 First-Quarter Financial Resul .. ers on Commercial Activity and Key Clinical Progr

[ Thu, Apr 26th 2012 ] - Market Wire

Amylin Pharmaceuticals Reports First Quarter 2012 Financial Results

[ Thu, Apr 26th 2012 ] - Market Wire

Celgene Reports First Quarter 2012 Operating and Financial Results

[ Thu, Apr 26th 2012 ] - Market Wire

Invacare Corporation Announces Financial Results for the First Quarter of 2012

[ Thu, Apr 26th 2012 ] - Market Wire

Watson acquiert le groupe Actavis pour 4,25 Milliards d'Euros

[ Thu, Apr 26th 2012 ] - Market Wire

Watson to Acquire Actavis Group for EUR 4.25 Billion

[ Thu, Apr 26th 2012 ] - Market Wire

Shire Reports Positive Phase 2 Study Met Primary .. se of Vyvanse (lisdexamfetamine dimesylate) Capsu

[ Thu, Apr 26th 2012 ] - Market Wire

Simcere Pharmaceutical Group Filed 2011 Annual Report on Form 20-F

[ Thu, Apr 26th 2012 ] - Market Wire

Forest Laboratories, Inc. and Pierre Fabre Medica .. Phase III Study for Levomilnacipran in Patients w

Wed, April 25, 2012

[ Wed, Apr 25th 2012 ] - Market Wire

AstraZeneca and The Medicines Company Announce Gl .. bal Collaboration in Acute Ischemic Heart Disease

[ Wed, Apr 25th 2012 ] - Market Wire

ProMetic Receives $1.9 Million Follow-On Order From a US Based Biopharmaceutical Company

[ Wed, Apr 25th 2012 ] - Market Wire

Gentiva Health Services To Present at Deutsche Bank and Bank of America Merrill Lynch Conferences

[ Wed, Apr 25th 2012 ] - Market Wire

IGSM Discusses EarthStream.TV Next Generation

[ Wed, Apr 25th 2012 ] - Market Wire

Targacept Announces Reduction in Force and Plan to Focus Resources on Later-Stage Pipeline

[ Wed, Apr 25th 2012 ] - Market Wire

Providence Service Corporation to Report First Qu .. lts on Wednesday, May 9th After the Market Closes

[ Wed, Apr 25th 2012 ] - Market Wire

BIOLASE Files Patent Infringement Lawsuit Against European Competitor

[ Wed, Apr 25th 2012 ] - Market Wire

Lpath Receives First U.S. Patent for Anti-LPA Antibody, Lpathomab

[ Wed, Apr 25th 2012 ] - Market Wire

VistaGen Secures Key U.S. Patent Covering Stem Ce .. s Used to Test Drug Candidates for Liver Toxicity

[ Wed, Apr 25th 2012 ] - Market Wire

AVI BioPharma to Present Additional Data From the .. n for the Treatment of Duchenne Muscular Dystroph

[ Wed, Apr 25th 2012 ] - Market Wire

Cantel Medical Appoints Seth M. Yellin As Vice President Of Corporate Development

[ Wed, Apr 25th 2012 ] - Market Wire

Humana Military Named in the Top 25 for Military Timesa 2012 aBest Employers for Vetsa

[ Wed, Apr 25th 2012 ] - Market Wire

ARIAD to Webcast Conference Call on First Quarter 2012 Financial Results

[ Wed, Apr 25th 2012 ] - Market Wire

Threshold Pharmaceuticals Appoints Robert Simon as Senior Vice President of Regulatory Affairs

[ Wed, Apr 25th 2012 ] - Market Wire

HeartWare Stock Trading Halted Today;; FDA .. w HeartWare Ventricular Assist System as a Bridge

[ Wed, Apr 25th 2012 ] - Market Wire

Acorda Therapeutics Presents AMPYRA Long-Term Saf .. 64th American Academy of Neurology Annual Meeting

[ Wed, Apr 25th 2012 ] - Market Wire

VentriPoint Signs Joint Development Agreement With Brand Name Global Ultrasound Manufacturer

[ Wed, Apr 25th 2012 ] - Market Wire

BioCryst to Report First Quarter 2012 Financial Results on May 7, 2012

[ Wed, Apr 25th 2012 ] - Market Wire

Illumina Introduces BaseSpace Apps, Solutions for Genome Informatics

Tue, April 24, 2012

[ Tue, Apr 24th 2012 ] - Market Wire

Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company

[ Tue, Apr 24th 2012 ] - Market Wire

FDA Approves Use of Codexis Enzymes in Merck Manufacturing Process

[ Tue, Apr 24th 2012 ] - Market Wire

InfuSystem Announces Agreement With Investor Group Regarding 2012 Annual Meeting of Stockholders

[ Tue, Apr 24th 2012 ] - Market Wire

Law Office of Brodsky amp;; Smith, LLC Announces Investigation of Ardea Biosciences, Inc.

[ Tue, Apr 24th 2012 ] - Market Wire

Dr. Reddyas Announces the Launch of Olanzapine Tablets

[ Tue, Apr 24th 2012 ] - Market Wire

ProMetic Signs a $1.4 Million Agreement With European Biotech Company

[ Tue, Apr 24th 2012 ] - Market Wire

An Unprecedented Data Point, The Single-Treatment .. patitis C Virus (HCV) by the Aethlon Hemopurifier

[ Tue, Apr 24th 2012 ] - Market Wire

Graymark Healthcare Opens Four New Facilities for Sleep Medicine Services

[ Tue, Apr 24th 2012 ] - Market Wire

JDRF Announces Research Collaboration with Dexcom .. 9;Smart Transmitterquot;; Technology to Ac

[ Tue, Apr 24th 2012 ] - Market Wire

Les rsultats positifs de l'essai clinique de phas .. acit et lainnocuit du BG-12 sous forme orale dans

[ Tue, Apr 24th 2012 ] - Market Wire

I risultati positivi dello studio clinico CONFIRM .. acia e la sicurezza del farmaco orale BG-12 per l

[ Tue, Apr 24th 2012 ] - Market Wire

Mylan Launches Generic Version of Zyprexa Tablets

[ Tue, Apr 24th 2012 ] - Market Wire

ICON reports a 10% increase in first quarter 2012 .. r on year, EPS of 15 cents, net new business awar

[ Tue, Apr 24th 2012 ] - Market Wire

Simcere Pharmaceutical Group to Announce First Qu .. 2012 Financial Results on Wednesday, May 9, 2012

[ Tue, Apr 24th 2012 ] - Market Wire

Ironwood?Forest??FDA??Linaclotide???????2012?9?

[ Tue, Apr 24th 2012 ] - Market Wire

Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference

[ Tue, Apr 24th 2012 ] - Market Wire

OMONTYS (Peginesatide) Injection Now Available fo .. e (CKD) Patients on Dialysis in the United States

[ Tue, Apr 24th 2012 ] - Market Wire

Illumina Launches MyGenome App for iPad

[ Tue, Apr 24th 2012 ] - Market Wire

Orthofix International Announces Signing of Agree .. Business Unit to Water Street Healthcare Partners

Mon, April 23, 2012

[ Mon, Apr 23rd 2012 ] - Market Wire

Bausch + Lomb and ISTA Pharmaceuticals Announce E .. y Termination of Hart-Scott-Rodino Waiting Period

[ Mon, Apr 23rd 2012 ] - Market Wire

ViroPharma To Release 2012 First Quarter Financial Results On May 1, 2012

[ Mon, Apr 23rd 2012 ] - Market Wire

Isis Pharmaceuticals Holds Webcast to Discuss Clinical Development Plans for ISIS-APOCIIIRx

[ Mon, Apr 23rd 2012 ] - Market Wire

The Law Firm of Levi & Korsinsky, LLP Announces I .. eaches of Fiduciary Duty by the Board of Ardea Bi

[ Mon, Apr 23rd 2012 ] - Market Wire

MSA Names Steve Blanco Vice President of Global Operational Excellence

[ Mon, Apr 23rd 2012 ] - Market Wire

Ironwood et Forest annoncent le prolongement par .. 'examen portant sur le linaclotide septembre 2012

[ Mon, Apr 23rd 2012 ] - Market Wire

Abbott and St. Jude Medical Broaden Alliance for Cardiovascular Products in the United States

[ Mon, Apr 23rd 2012 ] - Market Wire

Catasys, Inc. Announces $3.4 Million Private Placement Led by Affiliate of Chief Executive Officer

[ Mon, Apr 23rd 2012 ] - Market Wire

Nuevos datos presentados en el 64 Congreso Anual .. Biogen Idec para ofrecer terapias prometedoras p

[ Mon, Apr 23rd 2012 ] - Market Wire

Cynapsus Therapeutics Appoints Dr. Abraham Lieberman to Clinical Advisory Board

[ Mon, Apr 23rd 2012 ] - Market Wire

Alnylam Elects Dr. Dennis Ausiello to its Board of Directors and Scientific Advisory Board

[ Mon, Apr 23rd 2012 ] - Market Wire

Five Star Quality Care, Inc. First Quarter Conference Call Scheduled for Monday, April 30th

[ Mon, Apr 23rd 2012 ] - Market Wire

Ironwood und Forest melden Verlngerung des Prfung .. traums fr Linaclotid durch FDA bis September 2012

[ Mon, Apr 23rd 2012 ] - Market Wire

Natus Medical to Hold Conference Call on April 23

[ Mon, Apr 23rd 2012 ] - Market Wire

CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million

[ Mon, Apr 23rd 2012 ] - Market Wire

NeuroMetrix to Support Study at the Joslin Diabetes Center

[ Mon, Apr 23rd 2012 ] - Market Wire

Delcath Systems, Inc. Secures $20 Million Credit Facility

[ Mon, Apr 23rd 2012 ] - Market Wire

OncoSec ElectroChemotherapy Demonstrates Potentia .. tive to Surgery for Treating Head and Neck Cancer

[ Mon, Apr 23rd 2012 ] - Market Wire

PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award

Sun, April 22, 2012

[ Sun, Apr 22nd 2012 ] - Market Wire

AstraZeneca to Acquire Ardea Biosciences for $1.2 .. oduct Lesinurad in Phase III Development for Gout

[ Sun, Apr 22nd 2012 ] - Market Wire

The Law Firm of Levi amp;; Korsinsky Notif .. Their Investment in China Sky One Medical, Inc. o

[ Sun, Apr 22nd 2012 ] - Market Wire

The Law Firm of Levi & Korsinsky Notifies Investo .. tment in China Sky One Medical, Inc. of Class Act

Sat, April 21, 2012

[ Sat, Apr 21st 2012 ] - Market Wire

Auf der 64. AAN-Jahrestagung prsentierte Daten un .. on Biogen Idec in der Entwicklung vielversprechen

Fri, April 20, 2012

[ Fri, Apr 20th 2012 ] - Market Wire

Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer

[ Fri, Apr 20th 2012 ] - Market Wire

PROLOR Biotech Receives Letter from NYSE Amex Reg .. cord Date for 2012 Annual Meeting of Stockholders

[ Fri, Apr 20th 2012 ] - Market Wire

New Data Presented at 64th AAN Annual Meeting Hig .. ent to Deliver Promising Therapies for Unmet Need

[ Fri, Apr 20th 2012 ] - Market Wire

Warnex Refinances its Operations and Lists on the TSX Venture Exchange

[ Fri, Apr 20th 2012 ] - Market Wire

Quidel Receives CLIA Waiver for Its Sofia(TM) Ana .. Sofia Influenza A+B Fluorescent Immunoassay (FIA)

[ Fri, Apr 20th 2012 ] - Market Wire

Aetna Signs Contract Extension with WakeMed

[ Fri, Apr 20th 2012 ] - Market Wire

Human Genome Sciences to Sponsor Conference Call to Discuss First Quarter 2012 Financial Results

[ Fri, Apr 20th 2012 ] - Market Wire

Cannabis Science Signs Andrew Pitsicalis as Inter .. Director, Rockin Artwork Grants Cannabis Science

[ Fri, Apr 20th 2012 ] - Market Wire

Invacare Corporation to Host Conference Call to Discuss First Quarter 2012 Results

[ Fri, Apr 20th 2012 ] - Market Wire

Allos Therapeutics Announces Outcome of Request f .. examination of CHMP Opinion for FOLOTYN in Europe

[ Fri, Apr 20th 2012 ] - Market Wire

AMAG Pharmaceuticals Announces a Positive CHMP Op .. umoxytol in Europe for the Treatment of Iron Defi

[ Fri, Apr 20th 2012 ] - Market Wire

Incyte Announces EU Regulatory Milestone for Ruxolitinib

[ Fri, Apr 20th 2012 ] - Market Wire

Abbott Receives U.S. FDA Clearance to Use iFS Adv .. hnology for Arcuate Incisions in Cataract Surgery

[ Fri, Apr 20th 2012 ] - Market Wire

Watson to Host Conference Call and Webcast to Discuss First Quarter 2012 Earnings

[ Fri, Apr 20th 2012 ] - Market Wire

Research on HCA Holdings Inc. and Tenet Healthcar .. d Lawsuit Settlement Boosting Hospital's Revenues

[ Fri, Apr 20th 2012 ] - Market Wire

Immunovaccine Announces 2011 Year-End Results

[ Fri, Apr 20th 2012 ] - Market Wire

Thoratec Schedules First Quarter Conference Call, Webcast

[ Fri, Apr 20th 2012 ] - Market Wire

STAAR Surgical Celebrates Over 300,000 Successful Visian ICL Implants at ASCRS Congress

[ Fri, Apr 20th 2012 ] - Market Wire

Winner Medical's Special Committee Appoints Indep .. ndent Financial Advisor and Retains Legal Counsel

Thu, April 19, 2012

[ Thu, Apr 19th 2012 ] - Market Wire

Gilead anuncia ndices provisionales de respuesta .. 977 ms ribavirina en pacientes con hepatitis C de

[ Thu, Apr 19th 2012 ] - Market Wire

Humana Military to Host 75 Wounded, Ill, and Reco .. s at 90th Valero Texas Open in San Antonio, Texas

[ Thu, Apr 19th 2012 ] - Market Wire

Watson Confirms Glumetza Patent Challenge

[ Thu, Apr 19th 2012 ] - Market Wire

Rosetta Genomics Receives Key European Patent in Oncology

[ Thu, Apr 19th 2012 ] - Market Wire

Synta to Host First-Quarter 2012 Conference Call on May 3, 2012

[ Thu, Apr 19th 2012 ] - Market Wire

CytoSorbents Receives European Trademark for CytoSorb(R)

[ Thu, Apr 19th 2012 ] - Market Wire

Cytokinetics Announces CK-2017357 Receives Fast T .. for the Potential Treatment of Amyotrophic Later

[ Thu, Apr 19th 2012 ] - Market Wire

Sequenom Announces National Agreement with Provider MultiPlan, Inc.

[ Thu, Apr 19th 2012 ] - Market Wire

EnteroMedics to Host First Quarter 2012 Financial .. sults Conference Call and Provide Business Update

[ Thu, Apr 19th 2012 ] - Market Wire

Given Imaging to Host First Quarter 2012 Financial Results Conference Call on May 9, 2012

[ Thu, Apr 19th 2012 ] - Market Wire

MSD Reports Phase III Study Results Evaluating An .. sed With VICTRELIS (boceprevir) Combination Thera

[ Thu, Apr 19th 2012 ] - Market Wire

Merck Reports Phase III Study Results Evaluating .. Used With VICTRELIS (boceprevir) Combination Ther

[ Thu, Apr 19th 2012 ] - Market Wire

ZELTIQ Announces Criminal Judgments in Its Favor Ordered by Court in South Korea

[ Thu, Apr 19th 2012 ] - Market Wire

State of Ohio Selects Healthways to Provide Comprehensive Population Health Management Program

[ Thu, Apr 19th 2012 ] - Market Wire

Marina Biotech Regains Intellectual Property Righ .. M) Technology for Agriculture and Veterinary Uses

[ Thu, Apr 19th 2012 ] - Market Wire

Human Genome Sciences Announces Unsolicited Offer .. ; HGS Board of Directors Authorizes Exploration o

[ Thu, Apr 19th 2012 ] - Market Wire

Gilead Announces Early Sustained Virologic Respon .. avirin in Genotype 1 Treatment-Nave Hepatitis C P

[ Thu, Apr 19th 2012 ] - Market Wire

Gilead Announces Sustained Virologic Response Dat .. 977 Plus Pegylated Interferon and Ribavirin in Ge

[ Thu, Apr 19th 2012 ] - Market Wire

Abbott Presents Positive Results from Interferon- .. Pilotquot;; Study for the Treatment of Hep

Wed, April 18, 2012

[ Wed, Apr 18th 2012 ] - Market Wire

Gilead Sciences zal deze week tijdens de European .. nieuwe gegevens presenteren over hepatitis B en C

[ Wed, Apr 18th 2012 ] - Market Wire

HealthSouth To Present At Investor Conferences In May

[ Wed, Apr 18th 2012 ] - Market Wire

Cubist Pharmaceuticals Reports First Quarter 2012 Financial Results

[ Wed, Apr 18th 2012 ] - Market Wire

Cytokinetics Announces Clinical Trial Data Relati .. ted at the 64th Annual Meeting of the American Ac

[ Wed, Apr 18th 2012 ] - Market Wire

Vertex Advances INCIVEKa" (telaprevir) and Broad .. elopment With Goal of Further Expanding and Impro

[ Wed, Apr 18th 2012 ] - Market Wire

Vertex fait progresser INCIVEKa" (tlaprvir) ainsi .. mdicaments au stade du dveloppement avec comme ob

[ Wed, Apr 18th 2012 ] - Market Wire

Onyx Pharmaceuticals to Report First Quarter 2012 Financial Results After Market on May 2, 2012

[ Wed, Apr 18th 2012 ] - Market Wire

New Studies Conducted By Spherix Support Use Of D .. e To Reduce And Stabilize Atherosclerotic Plaques

[ Wed, Apr 18th 2012 ] - Market Wire

[ Wed, Apr 18th 2012 ] - Market Wire

Cannabis Science in Final Negotiations to Purchas .. 00 Square Foot Cancer Centre in Arizona With Over

[ Wed, Apr 18th 2012 ] - Market Wire

Gilead Sciences presenta nuevos datos sobre la he .. o europeo sobre enfermedades hepticas esta semana

[ Wed, Apr 18th 2012 ] - Market Wire

Biojet Test Flight Program to Use Calyx's Operating Subsidiary's Carinata Feedstock

[ Wed, Apr 18th 2012 ] - Market Wire

Patient Safety Technologies, Inc. to Present at T .. h Brothers 9th Annual Small Cap Equity Conference

[ Wed, Apr 18th 2012 ] - Market Wire

Isis Pharmaceuticals Holds Webcast to Discuss Clinical Development Plans for ISIS-APOCIIIRx

[ Wed, Apr 18th 2012 ] - Market Wire

SeraCare Shareholders Approve Acquisition by Linden Capital Partners

[ Wed, Apr 18th 2012 ] - Market Wire

Pacific Safety Products Inc. Signs Letter of Inte .. Over Transaction With ArmorWorks Enterprises Cana

[ Wed, Apr 18th 2012 ] - Market Wire

Clinical Data Shows Patient Benefit of VISIUS Surgical Theatre by IMRIS

[ Wed, Apr 18th 2012 ] - Market Wire

Illumina Announces Preliminary Voting Results for 2012 Annual Meeting of Stockholders

Acura Pharmaceuticals to Host First Quarter 2012 Financial Results Conference Call on May 2, 2012

_{//health-fitness.news-articles.net/content/2012/ .. ncial-results-conference-call-on-may-2-2012.html}
^{Published in Health and Fitness on Tuesday, April 24th 2012 at 14:42 GMT by Market Wire}

April 24, 2012 17:30 ET

Acura Pharmaceuticals to Host First Quarter 2012 Financial Results Conference Call on May 2, 2012

PALATINE, IL--(Marketwire - Apr 24, 2012) - Acura Pharmaceuticals, Inc. (NASDAQ: [ ACUR ]), a specialty pharmaceutical company innovating [ abuse deterrent drugs ], today announced that the company plans to report financial results for the first quarter of 2012 following the close of financial markets on Tuesday, May 1, 2012. The company will host a conference call to discuss the results on Wednesday, May 2, 2012 at 8:30 a.m. ET.

To participate in the live conference call, please dial 888-857-6929 (U.S. and Canada) or 719-457-2658 (international) five to ten minutes prior to the start of the call. The participant passcode is 5534513. A live audio webcast will also be available through the "[ Investors ]" section of the company's website, [ http://www.acurapharm.com ].

A replay of the call will be available beginning May 2, 2012 at 11:30 a.m. ET and ending on May 16, 2012 on the company's website, and by dialing 888-203-1112 (U.S. and Canada) or 719-457-0820 (international). The replay participant code is 5534513.

About Acura Pharmaceuticals
Acura Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development and commercialization of product candidates intended to address [ medication abuse and misuse ], utilizing its proprietary AVERSION® and IMPEDE technologies. In June 2011, the U.S. Food and Drug Administration, or FDA, approved OXECTA® which incorporates the AVERSION technology. The Company has a development pipeline of additional AVERSION technology products including other opioids, stimulants and benzodiazepines and its IMPEDE technology for pseudoephedrine hydrochloride products.

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire